CD8A and neoplasm: However, CD8+ T cells themselves are also promoted by IFNγ (42) which could mean that if we reach a positive balance in the TME wherein the beneficial effects of IFNγ bridges the unfavourable effects of PD-L1, the net contribution may be an improved tumour surveillance.